Welcome to BlueReg

European Regulatory Consultancy

We are an expanding regulatory affairs consultancy supporting pharmaceutical companies in their ability to develop and offer healthcare products to patients, including innovative treatment.

 

BlueReg will provide you strategic advice and tailored solutions to effectively overcome your regulatory challenges during the entire lifecycle of your company medicinal products.

Pharmaceutical consulting for life sciences industry
Pharmaceutical consulting for life sciences industry Pharmaceutical consulting for life sciences industry

Our clients

Biopharmaceutical Companies developing a first major product navigating into the different steps of development or reaching the registration phase.

 

Pharmaceutical Companies looking to introduce their first product on the EU Market and possibly accelerate via early access paths.

 

Lifesciences Companies looking to ensure regulatory compliance during the commercialization of their products.

Learn more about BlueReg

Pharmaceutical consulting for life sciences industry Pharmaceutical consulting for life sciences industry Pharmaceutical consulting for life sciences industry Pharmaceutical consulting for life sciences industry
Pharmaceutical consulting for life sciences industry
BlueReg staff standing on blocs celebrating BlueReg success indicators

+70

Full Time highly

QUALIFIED CONSULTANTS

Coming from pharma industry (Pharmacists, Engineers, PhD with scientific & regulatory backgrounds)

+25

ONGOING PROJECTS

with NASDAQ listed Biotechs

Developing “niche” products: orphan disease, unmet medicals needs, specific conditions, pediatrics indications

+100

PARTNERS

to cover 125 countries

Worldwide Network of partners to operate at a global or national level

Our Clients profiles

Biotech :
ATMP product

  • Drug Development

Pharmaceutical consulting for life sciences industry Company size:  30+ Employees

Biopharmaceutical Company developing a first major ATMP product looking to start interactions with EMA (European Medicines Agency).

from :

VP Global Regulatory Affairs

BlueReg is exactly what I expect from a regulatory consultancy. Trusted advicer, they are doing marvelous work, sometimes tells you the hard truth but this really improves our processes and our ways of working. This is really appreciated. BlueReg experts are versatile, expert and a high achiever. We would therefore consider to extend our collaboration for post MAA activities.

Pharmaceutical consulting for life sciences industry
Discover their case

Biotech :
Orphan Drug

  • Early Access to market

Pharmaceutical consulting for life sciences industry Company size:  100+ Employees

US biopharmaceutical company looking to introduce their first gene therapy on the EU Market by taking advantage of early access paths.

from :

General Manager Europe

Congratulations for this achievement and I want to thank you and the rest of the BlueReg team for the work that was put in the onboarding and getting familiar with our processes and procedures.

This demonstrates a very professional approach and commitment to deliver us the support that we are looking for.

Pharmaceutical consulting for life sciences industry
Discover their case

Large Pharma:
Multiple products

  • Promotional Material Review

Pharmaceutical consulting for life sciences industry Company size:  500+ Employees

Lifesciences Company looking to ensure regulatory compliance during the commercialization of their products in Europe.

from :

VP European Regulatory Affairs

Thank you very much for all your support in 2021!

This has been (another) eventful year, with unexpected twists and turns.

It’s good to know that we can rely on business partners like you.

Pharmaceutical consulting for life sciences industry
Discover their case
Pharmaceutical consulting for life sciences industry

The four Pillars of BlueReg

Experienced team

BlueReg is a pharmaceutical consulting company which operates since more than 10 years in the pharmaceutical industry partnering with life sciences companies in their ability to develop innovative drug products in compliance with regulations.

Our collaborative approach is built on our independence, our regulatory affairs hands-on experience, but also on our intrinsic understanding of the needs of pharmaceutical companies in the life sciences industry.

As a pharmaceutical industry consultancy, we are committed to ensure that each client enjoys optimum tailored solutions support in its regulatory affairs strategy and decision-making processes through all stages of product development, registration and launch activities.

We support pharmaceutical companies in their corporate strategy providing consulting services to overcome real and perceived challenges of the regulatory environment, in order to launch their innovative treatment solutions that will improve patients’ quality of life.

Rare skills provider

BlueReg has extensive experience partnering with biotech and multinational pharmaceutical companies developing drugs for serious unmet medical needs such as Orphan Drugs in the field of rare or serious disease.

We also partner with pharmaceutical companies looking to optimize time to market and provide access to our extensive experience in registration strategies.

As a pharma consultancy, we provide our clients with highly qualified consultants able to plug to their organization in a specific regulatory areas or target market.

# pharma consulting agency

Immediate activation

We support pharmaceutical companies with strategic consulting through all stages of product development, from clinical research, registration to the launch of innovative products on the market.

With our collaborative approach we aim to ensure efficient and effective interactions with health authorities protecting your projects and reputation. We also help companies to take ownership of their regulatory affairs through tailor-made solutions.

# consulting for pharma

Peace of mind

We, as consultant for the pharmaceutical industry, offers access to cross functional teams and tailored solution to help life sciences organizations to reach their businesses objectives achieving optimum support for product development; registration and launch activities, as well as early access programs.

Our services will give you an additional value as we can partner with your existing internal regulatory affairs team, providing advice and access to our expertise and experts personal experience in healthcare industries.

# pharma consultancy services

Our locations

Boston

Cambridge Innovation Center
One Broadway
Cambridge, MA 02142, USA

Google Maps

New York

62 William Street, 8th Floor
New York 10005, USA

Google Maps

San Francisco

201 Mission Street
San Francisco, CA 94105, USA

Google Maps

Paris

9 avenue percier
75008 Paris, France

+33 (0)1 82 73 10 00

Google Maps

Sophia Antipolis

1800 route des crêtes
Les Deux Arcs - Bât A
06560 Sophia Antipolis, France

Google Maps

London

Buckingham Court, Kingsmead Business Park
High Wycombe, Bucks
HP11 1JU, United Kingdom

Google Maps

Amsterdam

Gustav Mahlerplein 2
1082 MA Amsterdam, Netherlands

Google Maps

Zug

Baarerstrasse 14
6300 Zug, Switzerland

Google Maps

Boston

Cambridge Innovation Center
One Broadway
Cambridge, MA 02142, USA

Google Maps

New York

62 William Street, 8th Floor
New York 10005, USA

Google Maps

San Francisco

201 Mission Street
San Francisco, CA 94105, USA

Google Maps

Paris

9 avenue percier
75008 Paris, France

+33 (0)1 82 73 10 00

Google Maps

Sophia Antipolis

1800 route des crêtes
Les Deux Arcs - Bât A
06560 Sophia Antipolis, France

Google Maps

London

Buckingham Court, Kingsmead Business Park
High Wycombe, Bucks
HP11 1JU, United Kingdom

Google Maps

Amsterdam

Gustav Mahlerplein 2
1082 MA Amsterdam, Netherlands

Google Maps

Zug

Baarerstrasse 14
6300 Zug, Switzerland

Google Maps
Pharmaceutical consulting for life sciences industry

The latest resources

Coordination and Regulatory support across Europe for an innovative product/orphan drug

The Vice-President Global Regulatory Affairs of a US based company developing an important innovative product...

Download now

How to take advantage of incentives to develop your orphan products in Europe ?

As you want to start regulatory interactions in Europe for an orphan drug, you may...

Download now

Supporting a biopharmaceutical company not established in Europe accessing SME incentives granted by the European Medicines Agency

A US‑based client entrusted the European legal representation and the application/granting of their SME status...

Download now